Article
Mendelian Randomization Study on Serum Metabolites and Diabetic Nephropathy Risk: Identifying Potential Biomarkers for Early Intervention.
Current pharmaceutical design - 1 Jan 2026
Song Siyuan, Yu Jiangyi
Abstract excerpt
OBJECTIVE: In this study, the causation between serum metabolites and the risk of Diabetic Nephropathy (DN) was investigated by means of a Mendelian Randomization (MR) analysis. METHODS: Our data on diabetic nephropathy were obtained from the IEU OpenGWAS Project database, while serum metabolite data originated came from the GWAS summary statistics by Chen et al. The Inverse Variance Weighted (IVW) method was the...
Topics
- Humans
- Mendelian Randomization Analysis
- Diabetic Nephropathies
- Biomarkers
- Polymorphism, Single Nucleotide
- Risk Factors
